Gadobutrol Injectable Solution bulk supplier for pharma manufacturers

Gadobutrol Injectable Solution 1.0 mol/L Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 1.0 mol/L

Reference Brands: Gadavist(US & EU)

Gadobutrol is a gadolinium-based contrast agent that enhances MRI images by shortening relaxation times, improving tissue contrast. It provides clear visualization of blood vessels, organs, and abnormalities. Benefits include high image quality, safety, rapid clearance, and support for accurate diagnosis in neurological, cardiovascular, and musculoskeletal imaging.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Gadobutrol injectable solution, marketed as Gadavist, is approved in the US by the FDA and in the EU via EMA for contrast-enhanced MRI procedures. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports swift approval, safe administration, and global availability, enhancing diagnostic accuracy in neurological, cardiovascular, and musculoskeletal imaging worldwide.

Gadobutrol Injectable Solution — third party manufacturing & bulk supply

Gadobutrol Injectable Solution 1.0 mol/L is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Gadobutrol Injectable Solution is supplied as Injectable Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Gadobutrol Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Gadobutrol Injectable Solution →

Back to Listing

Frequently Asked Questions

Gadobutrol Injectable Solution is listed as Injectable Solution in 1.0 mol/L. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Gadobutrol Injectable Solution is referenced against Gadavist(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.